MX2010004601A - Diespiro-1,2,4-trioxolano antimalarial. - Google Patents

Diespiro-1,2,4-trioxolano antimalarial.

Info

Publication number
MX2010004601A
MX2010004601A MX2010004601A MX2010004601A MX2010004601A MX 2010004601 A MX2010004601 A MX 2010004601A MX 2010004601 A MX2010004601 A MX 2010004601A MX 2010004601 A MX2010004601 A MX 2010004601A MX 2010004601 A MX2010004601 A MX 2010004601A
Authority
MX
Mexico
Prior art keywords
trioxolane
compounds
dispiro
group
cancer
Prior art date
Application number
MX2010004601A
Other languages
English (en)
Spanish (es)
Inventor
Jonathan L Vennerstrom
Jacques Chollet
Hugues Matile
William N Charman
Yuxiang Dong
Susan A Charman
Sergio Wittlin
Darren J Creek
Xiaofang Wang
Kamaraj Sriraghavan
Lin Zhou
Original Assignee
Medicines Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines Malaria Venture Mmv filed Critical Medicines Malaria Venture Mmv
Publication of MX2010004601A publication Critical patent/MX2010004601A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2010004601A 2007-10-31 2008-10-29 Diespiro-1,2,4-trioxolano antimalarial. MX2010004601A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/930,606 US8067620B2 (en) 2005-05-04 2007-10-31 Dispiro 1,2,4-trioxolane antimalarials
PCT/US2008/081579 WO2009058859A2 (en) 2007-10-31 2008-10-29 Dispiro 1,2,4-trioxolane antimalarials

Publications (1)

Publication Number Publication Date
MX2010004601A true MX2010004601A (es) 2010-05-27

Family

ID=40228026

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004601A MX2010004601A (es) 2007-10-31 2008-10-29 Diespiro-1,2,4-trioxolano antimalarial.

Country Status (19)

Country Link
US (1) US8067620B2 (cg-RX-API-DMAC7.html)
EP (1) EP2203457B1 (cg-RX-API-DMAC7.html)
JP (1) JP5559057B2 (cg-RX-API-DMAC7.html)
KR (1) KR101588468B1 (cg-RX-API-DMAC7.html)
CN (1) CN101842377B (cg-RX-API-DMAC7.html)
AU (1) AU2008318819C1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818121B8 (cg-RX-API-DMAC7.html)
CA (1) CA2702256C (cg-RX-API-DMAC7.html)
CY (1) CY1115148T1 (cg-RX-API-DMAC7.html)
DK (1) DK2203457T3 (cg-RX-API-DMAC7.html)
ES (1) ES2466319T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140435T1 (cg-RX-API-DMAC7.html)
MX (1) MX2010004601A (cg-RX-API-DMAC7.html)
PL (1) PL2203457T3 (cg-RX-API-DMAC7.html)
PT (1) PT2203457E (cg-RX-API-DMAC7.html)
RU (1) RU2493159C2 (cg-RX-API-DMAC7.html)
SI (1) SI2203457T1 (cg-RX-API-DMAC7.html)
UA (1) UA99742C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009058859A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067620B2 (en) 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
EP2670765B1 (en) 2011-01-31 2017-10-18 Viiv Healthcare Uk (No. 4) Limited C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
JP2015525224A (ja) * 2012-06-13 2015-09-03 メディツィニッシェ ウニヴァズィテート ヴィーン アミドフェノキシプロパノールアミン
CA2937752C (en) 2014-02-14 2023-02-07 The Regents Of The University Of California Cyclic peroxides as prodrugs for selective delivery of agents
EP3309156A1 (en) 2016-10-13 2018-04-18 MMV Medicines for Malaria Venture New anti-malarial agents
JP2019530712A (ja) 2016-10-13 2019-10-24 エムエムヴィ メディシンズ フォア マラリア ヴェンチャーＭｍｖ Ｍｅｄｉｃｉｎｅｓ Ｆｏｒ Ｍａｌａｒｉａ Ｖｅｎｔｕｒｅ 新規抗マラリア薬
US11246854B2 (en) 2017-05-16 2022-02-15 The Johns Hopkins University Ozonides for treating or preventing virus infections
US11072594B2 (en) 2017-06-27 2021-07-27 The Regents Of The University Of California Trioxolane agents
CN110878069A (zh) * 2019-12-09 2020-03-13 南京杰运医药科技有限公司 一种4-吗琳基-2-乙基哌嗪的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621062A (en) * 1966-10-25 1971-11-16 Sterling Drug Inc 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol
US3673222A (en) * 1969-11-26 1972-06-27 Sydney Archer 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof
US3682991A (en) * 1970-10-19 1972-08-08 Sterling Drug Inc 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US4916204A (en) 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4816478A (en) * 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
US5053342A (en) * 1987-12-24 1991-10-01 Litmus Concepts, Inc. Fecal occult blood test reagents
US5559145A (en) * 1988-06-01 1996-09-24 Oxaco S.A. 1,2,4-trioxane derivatives
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
JP2867529B2 (ja) * 1990-01-22 1999-03-08 三菱電機株式会社 投写型表示装置
US5216175A (en) * 1990-03-23 1993-06-01 Sri International Antimalarial analogs of artemisinin
US5219880A (en) * 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5510356A (en) * 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
US5171676A (en) * 1991-10-31 1992-12-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of introducing hydroxyl groups into artemisinin and its derivatives
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
KR950702436A (ko) * 1992-07-28 1995-07-29 자코부스 코르넬리스 라세르 가교 결합 양이온성 중합체 및 알콜실화 에테르를 함유하는 국소용 약학 조성물(pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether)
US5721209A (en) * 1995-02-03 1998-02-24 The Regents Of The University Of California Iron chelator and inhibitor of iron-mediated oxidant injury
US5780675A (en) * 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
US5578637A (en) * 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5672624A (en) * 1995-11-22 1997-09-30 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5817692A (en) * 1995-11-22 1998-10-06 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5932591A (en) * 1996-12-02 1999-08-03 Johns Hopkins University C3 substituted trioxanes useful as antiparasitic drugs
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
US20090042821A1 (en) * 2005-05-18 2009-02-12 Arno Appavoo Enose Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials

Also Published As

Publication number Publication date
EP2203457A2 (en) 2010-07-07
WO2009058859A2 (en) 2009-05-07
CN101842377A (zh) 2010-09-22
BRPI0818121B1 (pt) 2020-12-08
ES2466319T3 (es) 2014-06-17
RU2010121919A (ru) 2011-12-10
CN101842377B (zh) 2015-07-01
CY1115148T1 (el) 2016-12-14
PL2203457T3 (pl) 2014-08-29
RU2493159C2 (ru) 2013-09-20
PT2203457E (pt) 2014-06-06
BRPI0818121A2 (pt) 2015-11-17
EP2203457B1 (en) 2014-03-05
HRP20140435T1 (hr) 2014-06-20
US20080125411A1 (en) 2008-05-29
SI2203457T1 (sl) 2014-06-30
AU2008318819B2 (en) 2013-11-21
WO2009058859A3 (en) 2009-06-18
CA2702256C (en) 2017-09-26
AU2008318819C1 (en) 2014-04-24
US8067620B2 (en) 2011-11-29
UA99742C2 (en) 2012-09-25
DK2203457T3 (da) 2014-05-12
KR101588468B1 (ko) 2016-01-25
KR20100087199A (ko) 2010-08-03
JP5559057B2 (ja) 2014-07-23
HK1147092A1 (en) 2011-07-29
BRPI0818121B8 (pt) 2021-05-25
JP2011502131A (ja) 2011-01-20
CA2702256A1 (en) 2009-05-07
AU2008318819A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
MX2010004601A (es) Diespiro-1,2,4-trioxolano antimalarial.
WO2009091433A3 (en) Spiro and dispiro 1,2,4-trioxolane antimalarials
YU100703A (sh) 1,2,4-trioksolanski antimalarici
WO2005110994A3 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
WO2009124295A3 (en) Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
ZA200509486B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
PL2155758T3 (pl) Pochodne tetrahydrofuro[3,4-d]dioksolanu przeznaczone do stosowania w leczeniu infekcji wirusowych i raka
MX2010004576A (es) Derivados de pirimidina novedosos.
IL180286A0 (en) Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
ZA200805247B (en) Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
WO2009108383A3 (en) Substituted xanthine derivatives
IL179758A (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof and use of the same as medicaments
WO2007101247A3 (en) Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
CA2478146A1 (en) Spiro and dispiro 1,2,4-trioxolane antimalarials
TNSN07440A1 (en) Derivatives of pyrido [2,3 -d] pyrimidine, the preparation thereof, and the therapeutic application of the same
WO2010121675A3 (en) Thiazolyl-benzimidazoles
ZA200903566B (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
WO2010080414A3 (en) Substituted fno (2-[furan-2-yl] naphthalen-1-ol) derivatives as anti-cancer agents
PT2240456E (pt) Método para produção de derivados de 3,6-di-hidro-l,3,5- triazina a partir de derivados de metformina e de paraldeído
WO2007081694A3 (en) Derivatives of sulindac, use thereof and preparation thereof
WO2006023843A3 (en) Novel heterocycles
PL1898901T3 (pl) Stabilne postacie dawkowania spiro i dispiro 1, 2, 4-trioksolanowych związków przeciwmalarycznych
WO2005079464A3 (en) Vitamin d receptor antagonists and their use in treating asthma
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine

Legal Events

Date Code Title Description
FG Grant or registration